The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -0.68 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -3.38 — no flag raisedOK
- Earnings quality 93/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as CareDx, Inc. reports it. History and quarterly detail are in the app.
- Testing services revenue$274.5M
- Patient and digital solutions revenue$56.9M
- Product revenue$48.4M
Leadership changes
From CareDx, Inc.'s own filings, the day they're filed.
- Suresh Gunasekaran · director · appointmenteff. 2025-10-22
- Keith Kennedy · Chief Operating Officer · appointmenteff. 2024-09-12
- John W. Hanna · President · appointmenteff. 2024-04-15
Latest filings
- 8-K · Company announcement2026-06-15
- 10-Q · Quarterly report2026-04-28
- 8-K · Company announcement2026-04-28
- DEF 14A · Annual proxy (pay & governance)2026-04-27
- 8-K · Company announcement2026-04-16
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about CareDx, Inc., every answer cited🔒
- The Intelligence Brief — added when CareDx, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.